 |
answer text |
<p>The Department has not made a recent comparative assessment of the United Kingdom
level of research funding into Kawasaki disease with that of other European Union
member states.</p><p> </p><p>The EU has recently agreed to fund a Kawasaki disease
study led from Great Ormond Street Hospital/University College London. The trial,
which aims to recruit 262 children from 40 centres across Europe, will look at the
effectiveness of using of steroids in addition to the standard treatment for Kawasaki
syndrome, intravenous immunoglobulins. The award is for over €5 million in funding
for the trial to be run through a new European consortium, connect4children.</p><p>
</p><p>The National Institute for Health Research (NIHR) Imperial Biomedical Research
Centre was funded between 2013-18 to carry out a project on the ‘Genetic determinants
of Kawasaki disease for susceptibility and outcome’ with NIHR funding of £77,000.</p><p><strong>
</strong></p><p><strong> </strong></p>
|
 |
